메뉴 건너뛰기




Volumn 36, Issue 2, 2001, Pages 329-331

Successful treatment of an Epstein-Barr virus-associated B-cell lymphoproliferative disease in a child with acute lymphoblastic leukemia using an anti-CD20 monoclonal antibody

Author keywords

Acute lymphoblastic leukemia; Child; Epstein Barr virus; Lymphoproliferative disorder; Monoclonal antibody

Indexed keywords

CD20 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD20; RITUXIMAB; UNCLASSIFIED DRUG;

EID: 0035143652     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20010201)36:2<329::AID-MPO1077>3.0.CO;2-F     Document Type: Article
Times cited : (11)

References (11)
  • 2
    • 0032170108 scopus 로고    scopus 로고
    • Infusion of cytotoxic cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
    • (1998) Blood , vol.92 , pp. 1549-1555
    • Rooney, C.M.1    Smith, C.A.2    Loftin, S.K.3
  • 3
    • 0032211189 scopus 로고    scopus 로고
    • Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: Prognostic factors and long-term outcome
    • (1998) Blood , vol.92 , pp. 3137-3147
    • Benkerrou, M.1    Jais, J.P.2    Leblond, V.3
  • 4
  • 9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.